Sanofi Dupixent gets European Commission nod for children aged 6 months to 5 years old with severe atopic dermatitis Ruchika Sharma22 March 2023 7:15 AM GMTDupixent is an injection administered under the skin at different injection sites.
CDSCO Panel grants Sanofi's Protocol Amendment Proposal for Quadrivalent Meningococcal Conjugate Vaccine Dr. Divya Colin19 March 2023 12:15 PM GMTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved Sanofi Healthcare's...
Sanofi cuts US list price of Lantus, its most-prescribed insulin by 78 percent Ruchika Sharma17 March 2023 6:45 AM GMTParis: Sanofi has announced that it will cut the list price of Lantus (insulin glargine injection) 100 Units/mL, its most widely prescribed insulin in...
Sanofi to acquire Provention Bio for USD 2.9 billion Ruchika Sharma13 March 2023 10:00 AM GMTParis: Sanofi and Provention Bio, Inc have entered into an agreement under which Sanofi has agreed to acquire Provention Bio, Inc., for $25.00 per...
Sanofi Dupixent application for treatment of chronic spontaneous urticaria in adults, adolescents accepted for USFDA review Ruchika Sharma7 March 2023 10:00 AM GMTDupixent is a fully human monoclonal antibody that inhibits the signaling of the IL-4 and IL-13 pathways and is not an immunosuppressant.
Sanofi, Regeneron Pharma bag USFDA nod for Kevzara to treat polymyalgia rheumatica Ruchika Sharma2 March 2023 7:45 AM GMTPolymyalgia rheumatica often initially presents with pain and stiffness around the neck, shoulder and hip area and symptoms include fatigue, low-grade...
Glooko, Sanofi collaborate for SoloStar Pen Connectivity with New Device SoloSmart Ruchika Sharma26 Feb 2023 7:30 AM GMTPalo Alto: Glooko Inc. has announced that they have entered into a partnering agreement with Sanofi to increase their support of people living...
Sanofi gets USFDA nod for hemophilia A treatment ALTUVIIIO Ruchika Sharma24 Feb 2023 6:49 AM GMTHemophilia A is a rare, lifelong condition in which the ability of a person's blood to clot properly is impaired, leading to excessive bleeds and...
Johnson & Johnson names Ex-Sanofi Chief Dr John Reed as Executive Vice President, Pharmaceuticals, RnD Ruchika Sharma14 Feb 2023 6:45 AM GMTDr Reed previously served as Executive Vice President, Global Head of Research and Development for Sanofi and brings more than 35 years of biomedical...
Drugmaker Sanofi to let go of staff at vaccine plants in India as part of review Ruchika Sharma31 Jan 2023 8:00 AM GMTAbout 800 employees could be affected by the decision, two sources familiar with the matter said.
Sanofi Gets CDSCO panel nod to market Olipudase alfa for rare disease Dr. Divya Colin30 Jan 2023 12:30 PM GMTNew Delhi: Granting the local Phase III and phase IV clinical trial waiver in the country, the Subject Expert Committee (SEC) functional under the...
Sanofi Dupixent gets European Commission okay to treat eosinophilic esophagitis Ruchika Sharma30 Jan 2023 11:00 AM GMTDupixent is an injection administered under the skin (subcutaneous injection) at different injection sites.
